These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9368782)

  • 1. Antibody-based immunological therapies.
    Scott AM; Welt S
    Curr Opin Immunol; 1997 Oct; 9(5):717-22. PubMed ID: 9368782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preface: antibody therapies for cancer.
    Bonavida B
    Oncogene; 2007 May; 26(25):3592-3. PubMed ID: 17530012
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies in the therapy of colon cancer.
    Welt S; Ritter G
    Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype antibodies in cancer treatment.
    de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
    Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
    Scanlan MJ; Ritter G; Yin BW; Williams C; Cohen LS; Coplan KA; Fortunato SR; Frosina D; Lee SY; Murray AE; Chua R; Filonenko VV; Sato E; Old LJ; Jungbluth AA
    Cancer Immun; 2006 Jan; 6():2. PubMed ID: 16405301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of cancer: from vision to standard clinical practice.
    Huber CH; Wölfel T
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):367-74. PubMed ID: 15067541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antibodies as anticancer agents.
    Zafir-Lavie I; Michaeli Y; Reiter Y
    Oncogene; 2007 May; 26(25):3714-33. PubMed ID: 17530025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted immunotherapy of cancer: development of antibody-induced cellular immunity.
    Lu Y; Low PS
    J Pharm Pharmacol; 2003 Feb; 55(2):163-7. PubMed ID: 12635651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing immunotherapies for childhood cancer.
    Capsomidis A; Anderson J
    Arch Dis Child Educ Pract Ed; 2017 Jun; 102(3):162-165. PubMed ID: 27686652
    [No Abstract]   [Full Text] [Related]  

  • 16. ErbB-directed immunotherapy: antibodies in current practice and promising new agents.
    Friedländer E; Barok M; Szöllosi J; Vereb G
    Immunol Lett; 2008 Mar; 116(2):126-40. PubMed ID: 18201769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotypic network and tumor therapy. Proceedings of the First International Meeting of Immunological Approaches to Tumor Therapy by Antibodies and Tumor Cell Vaccines. Bonn, February 6, 1993.
    Hybridoma; 1993 Oct; 12(5):493-630. PubMed ID: 8300121
    [No Abstract]   [Full Text] [Related]  

  • 18. The translational potential for target validation and therapy using intracellular antibodies in oncology.
    Weidle UH; Maisel D; Brinkmann U; Tiefenthaler G
    Cancer Genomics Proteomics; 2013; 10(6):239-50. PubMed ID: 24336633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2.
    Wels W; Groner B; Hynes NE
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():113-28. PubMed ID: 8815001
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
    Zhang S; Zhang HS; Cordon-Cardo C; Ragupathi G; Livingston PO
    Clin Cancer Res; 1998 Nov; 4(11):2669-76. PubMed ID: 9829729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.